Cellectar Biosciences, Inc. — Director's Dealing 2025

Mar 13, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2025-01-10

Reporting Person: Longcor Jarrod (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-10	Common Stock	P	30000	$0.28	Acquired	83141	Direct